Φορτώνει......
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
Therapeutic agents aimed at inhibiting a single molecular target have not been successful in cancer therapy, but rather they impart resistance. However, multi-target inhibitors have shown promising results in circumventing the development of resistance and inducing apoptosis in cancer cells/tissues....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Nanomedicine |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove Medical Press
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5863640/ https://ncbi.nlm.nih.gov/pubmed/29593389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S124701 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|